<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>12487966</identifier>
<setSpec>0025-7753</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pulido Ortega, Federico</dc:author>
<dc:author>Olivia, Juan</dc:author>
<dc:author>Costa Cerdá, Asunción</dc:author>
<dc:author>Callau Cabrera, Pilar</dc:author>
<dc:author>Gonzáles de Suso, Miguel Torralba</dc:author>
<dc:author>Hernández Albujar, Susana</dc:author>
<dc:author>Santos González, Jesús</dc:author>
<dc:author>Gatell Artigas, José M</dc:author>
<dc:author>Ocampo Hermida, Antonio</dc:author>
<dc:author>Arribas López, José Ramón</dc:author>
<dc:author>Mallotas Masferrer, José</dc:author>
<dc:author>Sanz Baena, Susana</dc:author>
<dc:author>Moreno Zamora, Ana</dc:author>
<dc:author>del Llano Señarís, Juan</dc:author>
<dc:author>Montes Ramiréz, M Luisa</dc:author>
<dc:author>Cepeda Gonzáles, Concepción</dc:author>
<dc:author>Barros Aguado, Carlos</dc:author>
<dc:author>Díaz, Beatriz</dc:author>
<dc:author>González-Lahoz, Juan</dc:author>
<dc:author>Teira Cobo, Ramón M</dc:author>
<dc:author>López Aldeguer, José</dc:author>
<dc:author>Lorenzo Hernández, Alicia</dc:author>
<dc:author>Miralles Alvarez, Celia</dc:author>
<dc:author>Márquez Solero, Manuel</dc:author>
<dc:author>Coduras, Alicia</dc:author>
<dc:author>Burgos Ramírez, Angel</dc:author>
<dc:author>Moreno Guillén, Santiago</dc:author>
<dc:author>Salavert Lletí, Miguel</dc:author>
<dc:author>Tordera Higón, Pablo</dc:author>
<dc:author>Santamaría Jáuregui, Juan Miguel</dc:author>
<dc:author>Condes Moreno, Emilia</dc:author>
<dc:author>Palacios Muñoz, Rosario</dc:author>
<dc:description xml:lang="en">BACKGROUND AND OBJECTIVE To know the durability of consecutive regimens of antiretroviral treatment is important to design a long-term therapy, but there is not much information about this subject. PATIENTS AND METHOD Retrospective epidemiological study of a sample of 401 patients who began antiretroviral treatment between January 1997 and April 2000 at ten Spanish hospitals. The duration of each consecutive antiretroviral regimen was calculated and the reasons for modification and discontinuation were described. RESULTS In the 3 years and 3 months covered by the study, 48.6% of the patients received more than one regimen of therapy. Seventy five of the initial prescribed combinations included protease inhibitors. Median duration of consecutive lines of therapy was decreasing: 560, 360, 330 and 202 days for the first, second, third and fourth regimens, respectively. The main reason to modification was intolerance or toxicity (46.2, 49.1 and 47.1% for the first, second and third modification). A fifth of changes was originated by difficulties to follow the therapy. Virological failure was the reason for modification in 21.8, 24.5 and 26.5% of first, second and third changes. CONCLUSIONS Duration of consecutive antiretroviral regimens progressively decreases. Intolerance or drug toxicity were the main reasons conditioning the change of treatment.</dc:description>
<dc:type>English Abstract</dc:type>
<dc:language>es</dc:language>
<dc:date>2002 Nov 30 </dc:date>
<dc:title xml:lang="es">Estudio epidemiológico retrospectivo sobre la duración del tratamiento de la infección por el virus de la inmunodeficiencia humana en España.</dc:title>
<dc:title xml:lang="en">[Retrospective epidemiological study on the durability of the treatment of HIV infection or AIDS in Spain].</dc:title>
<dc:publisher>Medicina clinica</dc:publisher>
</metadata>
</record>
</pubmed-document>
